Syneron Medical Ltd (ELOS) Tops Q3 EPS by 3c

Syneron Medical Ltd (Nasdaq: ELOS) reported Q3 EPS of $0.08, $0.03 better than the analyst estimate of $0.05. Revenue for the quarter came in at $71.5 million versus the consensus estimate of $68.08 million.

As of September 30, 2016, the Company's overall cash position, including cash and cash equivalents, short-term bank deposits and marketable securities, grew to $82.9 million from $76.7 million as of June 30, 2016.

For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.

You May Also Be Interested In

• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
• Microsoft stock target cut at Wolfe on higher capex estimates
• Morgan Stanley Resumes Tapestry Inc. (TPR) at Overweight